EP 1771164 A1 20070411 - MULTITHERAPY AGAINST CANCER
Title (en)
MULTITHERAPY AGAINST CANCER
Title (de)
MULTITHERAPIE GEGEN KREBS
Title (fr)
PLURITHERAPIE CONTRE LE CANCER
Publication
Application
Priority
- FR 2005001797 W 20050712
- FR 0407752 A 20040712
Abstract (en)
[origin: WO2006016062A1] The invention concerns a pharmaceutical composition for treating cancer characterized in that it comprises a combination of a PP2A methylating agent and an active principle selected among the group consisting of a phosphatase PP1 inhibitor, a histone diacetylase inhibitor, a direct or indirect pyruvate kinase activator, a PTEN agonist, a tyrosine kinase inhibitor, a Pl3 kinase inhibitor, a glucose competitor, a phosphoenol pyruvate carboxykinase inhibitor, a citrate synthase inhibitor and a latctate dehydrogenase inhibitor.
IPC 8 full level
A61K 31/00 (2006.01)
CPC (source: EP US)
A61K 31/00 (2013.01 - EP US); A61P 35/00 (2017.12 - EP)
Citation (search report)
See references of WO 2006016062A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
FR 2872704 A1 20060113; FR 2872704 B1 20071102; EP 1771164 A1 20070411; JP 2008505960 A 20080228; US 2007280918 A1 20071206; WO 2006016062 A1 20060216
DOCDB simple family (application)
FR 0407752 A 20040712; EP 05790826 A 20050712; FR 2005001797 W 20050712; JP 2007520862 A 20050712; US 57206805 A 20050712